Chemical Compound

Tacrolimus 19-epimer

CAS Registry Number 144490-63-1
Back to search Request a Quote
Tacrolimus 19-epimer chemical structure
Primary Record

Tacrolimus 19-epimer

In stock
9,550 g
Purity
98.1 %
CAS
144490-63-1

Compound Identifiers & Properties

CAS
144490-63-1
PubChem CID
13819073
SMILES
C[C@@H]1C[C@@H]([C@@H]2[C@H](C[C@H]([C@](O2)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@@H]([C@H](CC(=O)[C@@H](/C=C(/C1)\C)CC=C)O)C)/C(=C/[C@@H]4CC[C@H]([C@@H](C4)OC)O)/C)O)C)OC)OC
Canonical SMILES
C=CC[C@@H]1/C=C(\C)C[C@H](C)C[C@H](OC)[C@H]2O[C@](O)(C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@H](/C(C)=C/[C@@H]3CC[C@@H](O)[C@H](OC)C3)[C@H](C)[C@@H](O)CC1=O)[C@H](C)C[C@@H]2OC

Names & Synonyms

  • Tacrolimus 19-epimer
  • CN64Z1Q9FN
  • Tacrolimus anhydrous 19-epimer
  • UNII-CN64Z1Q9FN
  • Tacrolimus compound II
  • Tacrolimus EP Impurity G
  • Tacrolimus compound II [EP]
  • RefChem:890201
  • 19-Epi FK-506
  • CHEBI:94694
  • Tacrolimus monohydrate impurity G
  • Tacrolimus monohydrate impurity G [EP]
  • BBF-05772
  • 144490-63-1
  • TACROLIMUS COMPOUND II [EP IMPURITY]
  • J557.381E
  • TACROLIMUS 19-EPIMER [USP IMPURITY]
  • TACROLIMUS COMPOUND II (EP IMPURITY)
  • Tacrolimus related compound, tacrolimus 19-epimer-[USP]
  • Tacrolimus 19-Epimer; Tacrolimus EP Impurity G
  • TACROLIMUS MONOHYDRATE IMPURITY G [EP IMPURITY]
  • BRD-K65261396-002-01-3
  • TACROLIMUS MONOHYDRATE IMPURITY G (EP IMPURITY)
  • Tacrolimus related compound, tacrolimus 19-epimer-(USP)
  • TACROLIMUS RELATED COMPOUND, TACROLIMUS 19-EPIMER-(USP IMPURITY)
  • TACROLIMUS RELATED COMPOUND, TACROLIMUS 19-EPIMER-[USP IMPURITY]
  • (1S,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-(prop-2-en-1-yl)-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone
  • (1S,9S,12S,13R,14S,17R,18E,21S,23S,24R,25S,27R)-1,14-dihydroxy-12-[(E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-23,25-dimethoxy-13,19,21,27-tetramethyl-17-prop-2-enyl-11,28-dioxa-4-azatricyclo[22.3.1.04,9]octacos-18-ene-2,3,10,16-tetrone
  • (3S,4R,5S,8R,12S,14S,15R,16S,18R,19S,26aS,E)-8-allyl-5,19-dihydroxy-3-((E)-1-((1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl)prop-1-en-2-yl)-14,16-dimethoxy-4,10,12,18-tetramethyl-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-hexadecahydro-3H-15,19-epoxypyrido[2,1-c][1]oxa[4]azacyclotricosine-1,7,20,21(4H,23H)-tetraone
  • (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19S,26aS)-5,19-dihydroxy-3-[(1E)-1-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]prop-1-en-2-yl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(prop-2-en-1-yl)-3,4,5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-octadecahydro-7H-15,19-epoxypyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(23H)-tetrone
  • (3S,4R,5S,8R,9E,12S,14S,15R,16S,18R,19S,26aS)-5,6,8,11,12,13,14,15,16,17,18,19,24,25,26,26a-Hexadecahydro-5,19-dihydroxy-3-[(E)-2-[(1R,3R,4R)-4-hydroxy-3-methoxycyclohexyl]-1-methylethenyl]-14,16-dimethoxy-4,10,12,18-tetramethyl-8-(2-propenyl)-15,19-epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclotricosine-1,7,20,21(4H,23H)-tetrone